Search results
After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next
BioPharma Dive via Yahoo Finance· 22 hours agoA vote against MDMA-assisted therapy set back a high-profile treatment. Proponents argue the panel...
US health experts vote against MDMA as treatment for PTSD
AFP via Yahoo News· 3 days agoA panel of US health experts convened by the Food and Drug Administration on Tuesday overwhelmingly...
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 3 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological ...
FDA panel picks JN.1 subvariant for fall COVID vaccines
The Hill via Yahoo News· 3 days agoThe expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in...
"Devastating news": Experts say DA's questionable decisions sink chance of pre-election TV trial
Salon.com· 2 days agoThe Wednesday order stalls proceedings against Trump and eight of his alleged co-conspirators’...
HISD mistakenly tells some students they had to repeat a grade: The Good, Bad, and Ugly of the week...
Houston Public Media· 20 hours agoThe Houston Matters panel of non-experts weighs in on stories from the week’s news and decides if...
Prince Harry skipped royal wedding to avoid 'awkward' encounter with estranged brother Prince...
Fox News· 13 hours agoOn Friday, the Prince of Wales attended the wedding of Hugh Grosvenor, the Duke of Westminster, and...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 3 days agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
Controversy Grows as FDA Panel Prepares to Review MDMA Drug
Medscape· 5 days agoA US Food and Drug Administration (FDA) expert panel will meet Tuesday to consider whether to...
US FDA panel to vote on data, risk profile of Lilly Alzheimer’s drug
WSAU Wausau· 2 days ago(Reuters) - A panel of outside experts to the U.S. health regulator will vote on Monday on whether...